Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

Luis A. Kluth(New York Hospital Queens), Peter C. Black(University of British Columbia), Bernard H. Bochner(Memorial Sloan Kettering Cancer Center), James W.F. Catto(University of Sheffield), Seth P. Lerner(Baylor College of Medicine), Arnulf Stenzl(University of Tübingen), Richard Sylvester(European Organisation for Research and Treatment of Cancer), Andrew J. Vickers(Memorial Sloan Kettering Cancer Center), Évanguelos Xylinas(Assistance Publique – Hôpitaux de Paris), Shahrokh F. Shariat(NewYork–Presbyterian Hospital)

European Urology

February 21, 2015

10.1016/j.eururo.2015.01.032

Cited by 276

Abstract

Related Papers

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al.|New England Journal of Medicine|2003|2.6k

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar et al.|Journal of Clinical Oncology|1999|728

Prognostic Factors for Recurrence and Followup Policies in the Treatment of Superficial Bladder Cancer: Report from the British Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)

Mahesh Parmar, Laurence S. Freedman, T. B. Hargreave et al.|The Journal of Urology|1989|259

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

Steven C. Smith, Alexander S. Baras, Garrett M. Dancik et al.|The Lancet Oncology|2011|148

Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy

Matthew D. Galsky, Erin Moshier, S. Krege et al.|Cancer|2013|96